Pericellular innervation of neurons expressing abnormally hyperphosphorylated tau in the hippocampal formation of Alzheimer's disease patients

Frontiers in Neuroanatomy

Volumn , Issue JUNE, 2010, Pages

  Blazquez Llorca, Lidia ^a,b   Garcia Marin, Virginia ^a,b   DeFelipe, Javier ^a,b  

^a UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

^b INSTITUTO CAJAL   (Spain)

Author keywords

Basket terminals; Chandelier terminals; GABAergic axons; Glutamatergic axons; Neurofibrillary tangles

Indexed keywords

TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENDRITE; DENTATE HILUS; DISEASE ASSOCIATION; DISEASE COURSE; ELECTRON MICROSCOPY; ENTORHINAL CORTEX; FEMALE; GABAERGIC SYSTEM; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INNERVATION; INTERNEURON; MALE; NERVE FIBER; NEUROFIBRILLARY TANGLE; NEUROPIL; NONHUMAN; PAIRED HELICAL FILAMENT; PARAHIPPOCAMPAL GYRUS; PERIRHINAL CORTEX; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SUBICULUM; SYNAPSE; ULTRASTRUCTURE;

EID: 80055060108     PISSN: 16625129     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnana.2010.00020     Document Type: Article

References (117)

1. Alafuzoff, I., Arzberger, T., Al-Sarraj, S., Bodi, I., Bogdanovic, N., Braak, H., Bugiani, O., Del Tredici, K., Ferrer, I., Gelpi, E., Giaccone, G., Graeber, M. B., Ince, P., Kamphorst, W., King, A., Korkolopoulou, P., Kovacs, G. G., Larionov, S., Meyronet, D., Monoranu, C., Parchi, P., Patsouris, E., Roggendorf, W., Seilhean, D., Tagliavini, F., Stadelmann, C., Streichenberger, N., Thal, D. R., Wharton, S. B., and Kretzschmar, H. (2008). Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol. 18, 484-496.
2. Alonso Adel, C., Li, B., Grundke-Iqbal, I., and Iqbal, K. (2006). Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity. Proc. Natl. Acad. Sci. U.S.A. 103, 8864-8869.
3. Alonso-Nanclares, L., and DeFelipe, J. (2005). Vesicular glutamate transporter 1 immunostaining in the normal and epileptic human cerebral cortex. Neuroscience 134, 59-68.
4. Alonso-Nanclares, L., Minelli, A., Melone, M., Edwards, R. H., DeFelipe, J., and Conti, F. (2004). Perisomatic glutamatergic axon terminals: a novel feature of cortical synaptology revealed by vesicular glutamate transporter 1 immunostaining. Neuroscience 123, 547-556.
5. Alzheimer, A. (1911). Über eine eigenartige Krankheitsfälle des späten Alters. Z. Gesamte Neurol Psychiatr. 4, 356-385.
6. Arellano, J. I., Munoz, A., Ballesteros-Yanez, I., Sola, R. G., and DeFelipe, J. (2004). Histopathology and reorganization of chandelier cells in the human epileptic sclerotic hippocampus. Brain 127, 45-64.
7. Arendt, T., Bruckner, M. K., Gertz, H. J., and Marcova, L. (1998). Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain. Neuroscience 83, 991-1002.
8. Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., and Van Hoesen, G. W. (1991). The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex 1, 103-116.
9. Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., and Hyman, B. T. (1992). Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631-639.
10. Bancher, C., Brunner, C., Lassmann, H., Budka, H., Jellinger, K., Wiche, G., Seitelberger, F., Grundke-Iqbal, I., Iqbal, K., and Wisniewski, H. M. (1989). Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res. 477, 90-99.
11. Bell, K. F., de Kort, G. J., Steggerda, S., Shigemoto, R., Ribeiro-da-Silva, A., and Cuello, A. C. (2003). Structural involvement of the glutamatergic presynaptic boutons in a transgenic mouse model expressing early onset amyloid pathology. Neurosci. Lett. 353, 143-147.
12. Bellocchio, E. E., Hu, H., Pohorille, A., Chan, J., Pickel, V. M., and Edwards, R. H. (1998). The localization of the brain-specific inorganic phosphate transporter suggests a specific presynaptic role in glutamatergic transmission. J. Neurosci. 18, 8648-8659.
13. Blinzinger, K., and Kreutzberg, G. (1968). Displacement of synaptic terminals from regenerating motoneurons by microglial cells. Z. Zellforsch. Mikrosk. Anat. 85, 145-157.
14. Bourne, J., and Harris, K. M. (2007). Do thin spines learn to be mushroom spines that remember? Curr. Opin. Neurobiol. 17, 381-386.
15. Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., and Del Tredici, K. (2006). Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 112, 389-404.
16. Braak, E., Braak, H., and Mandelkow, E. M. (1994). A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol. 87, 554-567.
17. Braak, H., and Braak, E. (1986). Ratio of pyramidal cells versus non-pyramidal cells in the human frontal isocortex and changes in ratio with ageing and Alzheimer's disease. Prog. Brain Res. 70, 185-212.
18. Braak, H., and Braak, E. (1987). Projection neurons of basolateral amygdaloid nuclei develop meganeurites in juvenile and adult human neuronal ceroid lipofuscinosis. Clin. Neuropathol. 6, 116-119.
19. Braak, H., and Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239-259.
20. Braak, H., and Braak, E. (1995). Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 16, 271-278.
21. Braak, H., Braak, E., and Kalus, P. (1989). Alzheimer's disease: areal and laminar pathology in the occipital isocortex. Acta Neuropathol. 77, 494-506.
22. Braak, H., Del Tredici, K., Schultz, C., and Braak, E. (2000). Vulnerability of select neuronal types to Alzheimer's disease. Ann. N. Y. Acad. Sci. 924, 53-61.
23. Brady, D. R., and Mufson, E. J. (1997). Parvalbumin-immunoreactive neurons in the hippocampal formation of Alzheimer's diseased brain. Neuroscience 80, 1113-1125.
24. Brion, J. P., Couck, A. M., Passareiro, E., and Flament-Durand, J. (1985). Neurofibrillary tangles of Alzheimer's disease: an immunohistochemical study. J. Submicrosc. Cytol. 17, 89-96.
25. Burkhalter, A. (2008). Many specialists for suppressing cortical excitation. Front. Neurosci. 2, 155-167.
26. Celio, M. R. (1986). Parvalbumin in most gamma-aminobutyric acid-containing neurons of the rat cerebral cortex. Science 231, 995-997.
27. Cente, M., Filipcik, P., Pevalova, M., and Novak, M. (2006). Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy. Eur. J. Neurosci. 24, 1085-1090.
28. Chaudhry, F. A., Reimer, R. J., Bellocchio, E. E., Danbolt, N. C., Osen, K. K., Edwards, R. H., and Storm-Mathisen, J. (1998). The vesicular GABA transporter, VGAT, localizes to synaptic vesicles in sets of glycinergic as well as GABAergic neurons. J. Neurosci. 18, 9733-9750.
29. Cobb, S. R., and Davies, C. H. (2005). Cholinergic modulation of hippocampal cells and circuits. J. Physiol. 562, 81-88.
30. Crystal, H., Dickson, D., Fuld, P., Masur, D., Scott, R., Mehler, M., Masdeu, J., Kawas, C., Aronson, M., and Wolfson, L. (1988). Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 38, 1682-1687.
31. DeFelipe, J. (1993). Neocortical neuronal diversity: chemical heterogeneity revealed by colocalization studies of classic neurotransmitters, neuropeptides, calcium-binding proteins, and cell surface molecules. Cereb. Cortex 3, 273-289.
32. DeFelipe, J. (1999). Chandelier cells and epilepsy. Brain 122(Pt 10), 1807-1822.
33. DeFelipe, J., and Fairen, A. (1993). A simple and reliable method for correlative light and electron microscopic studies. J. Histochem. Cytochem. 41, 769-772.
34. DeFelipe, J., and Farinas, I. (1992). The pyramidal neuron of the cerebral cortex: morphological and chemical characteristics of the synaptic inputs. Prog. Neurobiol. 39, 563-607.
35. DeFelipe, J., and Gonzalez-Albo, M. C. (1998). Chandelier cell axons are immunoreactive for GAT-1 in the human neocortex. Neuroreport 9, 467-470.
36. DeFelipe, J., Hendry, S. H., and Jones, E. G. (1989). Visualization of chandelier cell axons by parvalbumin immunoreactivity in monkey cerebral cortex. Proc. Natl. Acad. Sci. U.S.A. 86, 2093-2097.
37. Dickson, D. W., Crystal, H. A., Mattiace, L. A., Masur, D. M., Blau, A. D., Davies, P., Yen, S. H., and Aronson, M. K. (1992). Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging 13, 179-189.
38. Dumoulin, A., Rostaing, P., Bedet, C., Levi, S., Isambert, M. F., Henry, J. P., Triller, A., and Gasnier, B. (1999). Presence of the vesicular inhibitory amino acid transporter in GABAergic and glycinergic synaptic terminal boutons. J. Cell. Sci. 112(Pt 6), 811-823.
39. Duvernoy, H. M. (2005). The Human Hippocampus: Functional Anatomy, Vascularization and Serial Sections with MRI. Berlin, Heidelberg: Springer-Verlag.
40. Ferrer, I., Santpere, G., and van Leeuwen, F. W. (2008). Argyrophilic grain disease. Brain 131, 1416-1432.
41. Ferrer, I., Soriano, E., Tunon, T., Fonseca, M., and Guionnet, N. (1991). Parvalbumin immunoreactive neurons in normal human temporal neo-cortex and in patients with Alzheimer's disease. J. Neurol. Sci. 106, 135-141.
42. Fonseca, M., Soriano, E., Ferrer, I., Martinez, A., and Tunon, T. (1993). Chandelier cell axons identified by parvalbumin-immunoreactivity in the normal human temporal cortex and in Alzheimer's disease. Neuroscience 55, 1107-1116.
43. Fremeau, R. T. Jr., Troyer, M. D., Pahner, I., Nygaard, G. O., Tran, C. H., Reimer, R. J., Bellocchio, E. E., Fortin, D., Storm-Mathisen, J., and Edwards, R. H. (2001). The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 31, 247-260.
44. Freund, T. F., and Buzsaki, G. (1996). Interneurons of the hippocampus. Hippocampus 6, 347-470.
45. Garcia-Marin, V., Blazquez-Llorca, L., Rodriguez, J. R., Boluda, S., Muntane, G., Ferrer, I., and DeFelipe, J. (2009). Diminished perisomatic GABAergic terminals on cortical neurons adjacent to amyloid plaques. Front. Neuroanat. 3, 28.
46. Goedert, M., and Spillantine, M. G. (2006). "Neurodegenerative alphasynucleinopathies and tauopathies." in Basic Neurochemistry: Molecular, Cellular, and Medical Aspects, eds G. J. Siegel, R. W. Albers, S. T. Brady, and D. L. Price (Burlington, MA: Elsevier Academic Press), 745-760.
47. Gomez-Isla, T., Price, J. L., McKeel, D. W. Jr., Morris, J. C., Growdon, J. H., and Hyman, B. T. (1996). Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16, 4491-4500.
48. Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., and Binder, L. I. (1986). Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U.S.A. 83, 4913-4917.
49. Hernandez, F., and Avila, J. (2007). Tauopathies. Cell. Mol. Life Sci. 64, 2219-2233.
50. Hernandez, F., and Avila, J. (2008). Tau aggregates and tau pathology. J. Alzheimers Dis. 14, 449-452.
51. Hirano, A., and Zimmerman, H. M. (1962). Alzheimer's neurofibrillary changes. A topographic study. Arch. Neurol. 7, 227-242.
52. Hof, P. R., Cox, K., and Morrison, J. H. (1990). Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex. J. Comp. Neurol. 301, 44-54.
53. Hof, P. R., Cox, K., Young, W. G., Celio, M. R., Rogers, J., and Morrison, J. H. (1991). Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 50, 451-462.
54. Hof, P. R., Giannakopoulos, P., Vickers, J. C., Bouras, C., and Morrison, J. H. (1995). The morphologic and neurochemical basis of dementia: aging, hierarchical patterns of lesion distribution and vulnerable neuronal phenotype. Rev. Neurosci. 6, 97-124.
55. Hof, P. R., and Morrison, J. H. (1990). Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex. J. Comp. Neurol. 301, 55-64.
56. Houser, C. R., Barber, R. P., and Vaughn, J. E. (1984). Immunocytochemical localization of glutamic acid decarboxylase in the dorsal lateral vestibular nucleus: evidence for an intrinsic and extrinsic GABAergic innervation. Neurosci. Lett. 47, 213-220.
57. Howard, A., Tamas, G., and Soltesz, I. (2005). Lighting the chandelier: new vistas for axo-axonic cells. Trends Neurosci. 28, 310-316.
58. Hyman, B. T., and Gomez-Isla, T. (1994). Alzheimer's disease is a laminar, regional, and neural system specific disease, not a global brain disease. Neurobiol. Aging 15, 353-354.
59. Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., and Barnes, C. L. (1984). Alzheimer's disease: cellspecific pathology isolates the hippocampal formation. Science 225, 1168-1170.
60. Hyman, B. T., Van Hoesen, G. W., Kromer, L. J., and Damasio, A. R. (1986). Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann. Neurol. 20, 472-481.
61. Insausti, R., and Amaral, D. G. (2004). "Hippocampal formation," in The Human Nervous System, eds G. Paxinos, and J. K. Mai (San Diego, CA: Elsevier Academic Press), 872-915.
62. Iqbal, K., Alonso Adel, C., and Grundke-Iqbal, I. (2008). Cytosolic abnormally hyperphosphorylated tau but not paired helical filaments sequester normal MAPs and inhibit microtubule assembly. J. Alzheimers Dis. 14, 365-370.
63. Iqbal, K., Grundke-Iqbal, I., Zaidi, T., Merz, P. A., Wen, G. Y., Shaikh, S. S., Wisniewski, H. M., Alafuzoff, I., Winblad, B. (1986). Defective brain microtubule assembly in Alzheimer's disease. Lancet 2, 421-426.
64. Iwamoto, N., and Emson, P. C. (1991). Demonstration of neurofibrillary tangles in parvalbumin-immunoreactive interneurones in the cerebral cortex of Alzheimer-type dementia brain. Neurosci. Lett. 128, 81-84.
65. Jones, E. G. (1993). GABAergic neurons and their role in cortical plasticity in primates. Cereb. Cortex 3, 361-372.
66. Josephs, K. A., Whitwell, J. L., Parisi, J. E., Knopman, D. S., Boeve, B. F., Geda, Y. E., Jack, C. R. Jr., Petersen, R. C., and Dickson, D. W. (2008). Argyrophilic grains: a distinct disease or an additive pathology? Neurobiol. Aging 29, 566-573.
67. Kaneko, T., and Fujiyama, F. (2002). Complementary distribution of vesicular glutamate transporters in the central nervous system. Neurosci. Res. 42, 243-250.
68. Kasai, H., Matsuzaki, M., Noguchi, J., Yasumatsu, N., and Nakahara, H. (2003). Structure-stability-function relationships of dendritic spines. Trends Neurosci. 26, 360-368.
69. Katzman, R., Terry, R., DeTeresa, R., Brown, T., Davies, P., Fuld, P., Renbing, X., and Peck, A. (1988). Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23, 138-144.
70. Kidd, M. (1963). Paired helical filaments in electron microscopy of Alzheimer's disease. Nature 197, 192-193.
71. Kidd, M. (1964). Alzheimer's disease-an electron microscopical study. Brain 87, 307-320.
72. Klausberger, T., Marton, L. F., Baude, A., Roberts, J. D., Magill, P. J., and Somogyi, P. (2004). Spike timing of dendrite-targeting bistratified cells during hippocampal network oscillations in vivo. Nat. Neurosci. 7, 41-47.
73. Knafo, S., Alonso-Nanclares, L., Gonzalez-Soriano, J., Merino-Serrais, P., Fernaud-Espinosa, I., Ferrer, I., and DeFelipe, J. (2009a). Widespread changes in dendritic spines in a model of Alzheimer's disease. Cereb. Cortex 19, 586-592.
74. Knafo, S., Venero, C., Merino-Serrais, P., Fernaud-Espinosa, I., Gonzalez-Soriano, J., Ferrer, I., Santpere, G., and DeFelipe, J. (2009b). Morphological alterations to neurons of the amygdala and impaired fear conditioning in a transgenic mouse model of Alzheimer's disease. J. Pathol. 219, 41-51.
75. Kosik, K. S., Joachim, C. L., and Selkoe, D. J. (1986). Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 83, 4044-4048.
76. Lewis, D. A., Campbell, M. J., Terry, R. D., and Morrison, J. H. (1987). Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J. Neurosci. 7, 1799-1808.
77. Lorente de Nó, R. (1934). Studies on the structure of the cerebral cortex. II. Continuation of the study of the ammonic system. J. Psychol. Neurol. 46, 113-177.
78. Lowe, S. L., Francis, P. T., Procter, A. W., Palmer, A. M., Davison, A. N., and Bowen, D. M. (1988). Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease. Brain 111(Pt 4), 785-799.
79. Matsuo, E. S., Shin, R. W., Billingsley, M. L., Van deVoorde, A., O'Connor, M., Trojanowski, J. Q., Lee, V. M. (1994). Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 13, 989-1002.
80. Merchan-Perez, A., Rodriguez, J. R., Ribak, C. E., and DeFelipe, J. (2009). Proximity of excitatory and inhibitory axon terminals adjacent to pyramidal cell bodies provides a putative basis for nonsynaptic interactions. Proc. Natl. Acad. Sci. U.S.A. 106, 9878-9883.
81. Mikkonen, M., Alafuzoff, I., Tapiola, T., Soininen, H., and Miettinen, R. (1999). Subfield-and layer-specific changes in parvalbumin, calretinin and calbindin-D28K immunore-activity in the entorhinal cortex in Alzheimer's disease. Neuroscience 92, 515-532.
82. Miles, R., Toth, K., Gulyas, A. I., Hajos, N., and Freund, T. F. (1996). Differences between somatic and dendritic inhibition in the hippocampus. Neuron 16, 815-823.
83. Minelli, A., Alonso-Nanclares, L., Edwards, R. H., DeFelipe, J., and Conti, F. (2003). Postnatal development of the vesicular GABA transporter in rat cerebral cortex. Neuroscience 117, 337-346.
84. Minelli, A., Brecha, N. C., Karschin, C., DeBiasi, S., and Conti, F. (1995). GAT-1, a high-affinity GABA plasma membrane transporter, is localized to neurons and astroglia in the cerebral cortex. J. Neurosci. 15, 7734-7746.
85. Moran, L. B., and Graeber, M. B. (2004). The facial nerve axotomy model. Brain Res. Brain Res. Rev. 44, 154-178.
86. Morrison, B. M., Hof, P. R., and Morrison, J. H. (1998). Determinants of neuronal vulnerability in neurodegenerative diseases. Ann. Neurol. 44, S32-S44.
87. Morrison, J. H., and Hof, P. R. (2002). Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease. Prog. Brain Res. 136, 467-486.
88. Morrison, J. H., and Hof, P. R. (2007). Life and death of neurons in the aging cerebral cortex. Int. Rev. Neurobiol. 81, 41-57.
89. Mountjoy, C. Q., Roth, M., Evans, N. J., and Evans, H. M. (1983). Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol. Aging 4, 1-11.
90. Nägga, K., Bogdanovic, N., and Marcusson, J. (1999). GABA transporters (GAT-1) in Alzheimer's disease. J. Neural Transm. 106, 1141-1149.
91. Ni, B., Du, Y., Wu, X., DeHoff, B. S., Rosteck, P. R. Jr., and Paul, S. M. (1996). Molecular cloning, expression, and chromosomal localization of a human brain-specific Na(+)-dependent inorganic phosphate cotransporter. J. Neurochem. 66, 2227-2238.
92. Nunomura, A., Castellani, R. J., Zhu, X., Moreira, P. I., Perry, G., and Smith, M. A. (2006). Involvement of oxidative stress in Alzheimer disease. J. Neuropathol. Exp. Neurol. 65, 631-641.
93. Pearson, R. C., Esiri, M. M., Hiorns, R. W., Wilcock, G. K., and Powell, T. P. (1985). Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 82, 4531-4534.
94. Porzig, R., Singer, D., and Hoffmann, R. (2007). Epitope mapping of mAbs AT8 and Tau5 directed against hyper-phosphorylated regions of the human tau protein. Biochem. Biophys. Res. Commun. 358, 644-649.
95. Price, J. L., Davis, P. B., Morris, J. C., and White, D. L. (1991). The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol. Aging 12, 295-312.
96. Price, J. L., McKeel, D. W. Jr., Buckles, V. D., Roe, C. M., Xiong, C., Grundman, M., Hansen, L. A., Petersen, R. C., Parisi, J. E., Dickson, D. W., Smith, C. D., Davis, D. G., Schmitt, F. A., Markesbery, W. R., Kaye, J., Kurlan, R., Hulette, C., Kurland, B. F., Higdon, R., Kukull, W., and Morris, J. C. (2009). Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol. Aging 30, 1026-1036.
97. Reinikainen, K. J., Paljarvi, L., Huuskonen, M., Soininen, H., Laakso, M., and Riekkinen, P. J. (1988). A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease. J. Neurol. Sci 84, 101-116.
98. Ren, K., King, M. A., Liu, J., Siemann, J., Altman, M., Meyers, C., Hughes, J. A., and Meyer, E. M. (2007). The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohip-pocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice. Neuroscience 148, 230-237.
99. Rissman, R. A., De Blas, A. L., and Armstrong, D. M. (2007). GABA(A) receptors in aging and Alzheimer's disease. J. Neurochem. 103, 1285-1292.
100. Roberts, G. W., Crow, T. J., and Polak, J. M. (1985). Location of neuronal tangles in somatostatin neurones in Alzheimer's disease. Nature 314, 92-94.
101. Shimazaki, M., Nakano, H., and Kobayashi, K. (2005). Correlation between tau phosphorylation sites and tangle morphology in Alzheimer's disease. Psychogeriatrics 5, 22-35.
102. Smith, K. D., Kallhoff, V., Zheng, H., and Pautler, R. G. (2007). In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease. Neuroimage 35, 1401-1408.
103. Solodkin, A., Veldhuizen, S. D., and Van Hoesen, G. W. (1996). Contingent vulnerability of entorhinal parvalbumin-containing neurons in Alzheimer's disease. J. Neurosci. 16, 3311-3321.
104. Somogyi, P., Tamas, G., Lujan, R., and Buhl, E. H. (1998). Salient features of synaptic organisation in the cerebral cortex. Brain Res. Brain Res. Rev. 26, 113-135.
105. Spires, T. L., Meyer-Luehmann, M., Stern, E. A., McLean, P. J., Skoch, J., Nguyen, P. T., Bacskai, B. J., and Hyman, B. T. (2005). Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J. Neurosci. 25, 7278-7287.
106. Spires, T. L., Orne, J. D., SantaCruz, K., Pitstick, R., Carlson, G. A., Ashe, K. H., and Hyman, B. T. (2006). Regionspecific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Am. J. Pathol. 168, 1598-1607.
107. Spires-Jones, T. L., de Calignon, A., Matsui, T., Zehr, C., Pitstick, R., Wu, H. Y., Osetek, J. D., Jones, P. B., Bacskai, B. J., Feany, M. B., Carlson, G. A., Ashe, K. H., Lewis, J., and Hyman, B. T. (2008). In vivo imaging reveals dissociation between caspase activation and acute neuronal death in tangle-bearing neurons. J. Neurosci. 28, 862-867.
108. Spruston, N. (2008). Pyramidal neurons: dendritic structure and synaptic integration. Nat. Rev. Neurosci. 9, 206-221.
109. Stamer, K., Vogel, R., Thies, E., Mandelkow, E., and Mandelkow, E. M. (2002). Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 156, 1051-1063.
110. Terry, R. D. (1963). The fine structure of neurofibrillary tangles in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 22, 629-642.
111. Terry, R. D., Gonatas, N. K., and Weiss, M. (1964). Ultrastructural studies in Alzheimer's presenile dementia. Am. J. Pathol. 44, 269-297.
112. Terwel, D., Dewachter, I., and Van, Leuven F. (2002). Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease. Neuromolecular. Med. 2, 151-165.
113. Thal, D. R., Schultz, C., Botez, G., Del Tredici, K., Mrak, R. E., Griffin, W. S., Wiestler, O. D., Braak, H., and Ghebremedhin, E. (2005). The impact of argyrophilic grain disease on the development of dementia and its relationship to concurrent Alzheimer's disease-related pathology. Neuropathol. Appl. Neurobiol. 31, 270-279.
114. Tolnay, M., and Probst, A. (1999). REVIEW: tau protein pathology in Alzheimer's disease and related disorders. Neuropathol. Appl. Neurobiol. 25, 171-187.
115. Tsai, J., Grutzendler, J., Duff, K., and Gan, W. B. (2004). Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat. Neurosci. 7, 1181-1183.
116. Varoqui, H., Schafer, M. K., Zhu, H., Weihe, E., and Erickson, J. D. (2002). Identification of the differentiation-associated Na/PI transporter as a novel vesicular glutamate transporter expressed in a distinct set of glutamatergic synapses. J. Neurosci. 22, 142-155.
117. Young, A. B. (1987). Cortical amino acidergic pathways in Alzheimer's disease. J. Neural Transm. Suppl. 24, 147-152.